Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-04-10
2007-04-10
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S788000, C514S252170, C536S103000, C424S488000, C424S449000, C564S161000, C564S229000, C544S370000
Reexamination Certificate
active
11144965
ABSTRACT:
A pharmaceutical composition an inclusion complex and methods for treating patients and preparing said complex disclosed for transmucosal delivery comprising an inclusion complex of (a) alprazolam and (b) a water soluble 2-hydroxypropyl-beta-cyclodextrin, and a pharmaceutically acceptable carrier therefor, wherein all the alprazolam is present in ring-closed form.
REFERENCES:
patent: 5472954 (1995-12-01), Loftsson
patent: WO 99/42111 (1999-08-01), None
patent: WO 00/59475 (2000-10-01), None
patent: WO 02/060411 (2002-08-01), None
J.M. Scavone et al.; Alpracolam Kinetics Following Sublingual and Oral Administration; Journal; J. Clin. Pyschopharmacol; 1987, 7:332-334; Boston, MA.
Roderick B. Walker and Eric W. Smith; The Role of Percutaneous Penetration Enhancers; Journal; Advanced Drug Delivery Reviews; 18 1996 295-301.
Josef Szejtli: Cyclodextrin Technology; Kluer Academic Press; 1988; Journal; 79, 80-185.
J. Szejtli * K-H Fromming; Cyclodextrins in Pharmacy, Kluwer Academic Press; 19-32, 1988.
Loftsson et al; Improved Acitretin Delivery Through Hairless Mouse Skin by Cyclodextrin Complexation; International Journal of Pharmaceuticals 115; 1995, 255-258.
Volmer et al.; A study of Percutaneous Absorption-Enhancing Effects of Cyclodextrin Derivative in Rats; Journal; J. Pharm. 1994; 19-22.
Vollmer et al.; In Vivo Skin Pharmaceuticals of Liarozole; Percutaneous Absorbtion Studies with Different Formulations of Cyclodextrin Derivatives in Rats; International Jounal of Pharmaceutics 99 1993 51-58.
Legendre et al; Effects of B-Cyclodextrins on Skin: Implications for the Transdermal Delivery of Piribedil and a Novel Cognition Enhancing-Drug S-9977; Pharmaceutical Sciences European Jounal of Pharmaceutical Sciences 3 1995 311-322.
Merkus et al.; Absorbtion Enhancing Effect of Cyclodextrins on Intranasally Administered Insulin in Rats; Pharmaceutical Research, vol. 8 No. 5 1991 pp. 588-592.
Gill et al.; Cyclodextrins as Protection Agents Against Enhancer Damage in Nassal Delivery Systems I. Assessment of Effect by Measurement of Erythrocyte Haemolysis; Pharmaceutical Sciences; European Journal of Pharmaceutical Sciences 1 1994 229-236.
Stella et al. The Interaction of Charged and Uncharged Drugs with Neutral and Anionically Charged Cyclodextrin; Pharmaceutical Research 1995, 12 9 S205.
Bergeron et al.; Disposition Requirements for Binding in Aqueous Solution of Polar Substrates in the Cyclohexaamylose Cavity; Journal of the American Chemical Society 99:15; Jul. 20, 1977.
Loftsson et al.; Solubilization and Stabilization of Drugs Through Cyclodextrin Complexation; Acta Pharm. Nord 3(4) pp. 215-217; 1991.
Loftssib et ak.; The effect of Water Soluble Polymers on Drug-Cyclodextrin Complexation; International Journal of Pharmaceutics; 110; 1994 pp. 169-177.
Loftsson et al.; The Effect of Water Soluble Polymers on the Aqueous Solubility and Complexing Abilities of B-Cyclodextrin; International Journal of Pharmaceuticals 163; 1998 pp. 115-121.
Farmarc Nederland BV
Jiang Shaojia Anna
Keefer Timothy J.
Khare Devesh
Seyfarth Shaw LLP
LandOfFree
Alprazolam inclusion complexes and pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alprazolam inclusion complexes and pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alprazolam inclusion complexes and pharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3770868